Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
DALLAS, TX--(Marketwired - Jan 12, 2017) - BudCube Cultivation Systems (BCS), a subsidiary of Cherubim Interests, Inc. (OTC PINK: CHIT) ("the Company"), an expansion-stage alternative construction...
-
CLEARWATER, FL--(Marketwired - Jan 12, 2017) - Effective January 9, 2017, Endurance Exploration Group, Inc. ("EXPL") (OTCQB: EXPL) through a newly formed, wholly owned subsidiary, EXPL Great...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 12, 2017) - George W. Sanders, President of Goldcliff Resource Corporation (TSX VENTURE:GCN)(OTC PINK:GCFFF) (the Company) is pleased to...
-
MINNEAPOLIS, Jan. 12, 2017 (GLOBE NEWSWIRE) -- Northern Technologies International Corporation (NASDAQ:NTIC), a leading developer of corrosion inhibiting products and services, as well as bio-based...
-
BERLIN, GERMANY--(Marketwired - Jan. 12, 2017) - Note to editors: To view the photos associated with this press release, please visit the following links: ...
-
SAN JOSE, CA--(Marketwired - January 12, 2017) - Pulse Secure, the leader in secure access solutions, has announced that Pulse Connect Secure 8.2 and Pulse Policy Secure 5.3 on PSA-Series Appliances...
-
RALEIGH, NC--(Marketwired - Jan 11, 2017) - Icon Media Holdings, Inc. (OTC PINK: ICNM), a diversified global technology company that specializes in wireless infrastructure and technical services...
-
NEW YORK, Jan. 11, 2017 (GLOBE NEWSWIRE) -- PHI Group, a U.S. public company focusing on acquisitions and investments in special situations (http://www.phiglobal.com),...
-
TORONTO, ONTARIO--(Marketwired - Jan. 11, 2017) - Smart Real Estate Investment Trust (TSX:SRU.UN) and Mitchell Goldhar announced today that they have signed a 10 year (plus two 5 year...
-
STAMFORD, Conn., Jan. 10, 2017 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with...